Two months ago, Moderna trumpeted “positive” early data for its COVID-19 vaccine but didn’t offer the results in a scientific presentation or in a peer-reviewed study. Now, it’s showing us the receipts. The phase 1 study, being run by the…

Protection from any potential coronavirus vaccine might be short-lived and could require a booster to prolong protection, White House health advisor Dr. Anthony Fauci said Monday. As several companies move closer to the finish line of a potential vaccine for…